Premium
Effect of interleukin‐28B on treatment outcome in hepatitis C virus G1/4 patients receiving response‐guided therapy with pegylated interferon alpha‐2a/ribavirin
Author(s) -
Pearlman Brian L.,
Ehleben Carole
Publication year - 2012
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.25552
Subject(s) - ribavirin , medicine , hepatology , pegylated interferon , interleukin 28b , alpha interferon , hepatitis c virus , family medicine , hepatitis c , gastroenterology , immunology , interferon , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom